CBC-Backed Hasten Biopharmaceutical Announces Acquisition of 14 Celltrion Legacy Products
The deal leverages CBC’s hands-on “investor-operator” approach to accelerate portfolio companies’ asset acquisition and strategic international expansion SINGAPORE, June 30,…
